(Albany, US) DelveInsight has launched a new report on Neuromyelitis Optica Spectrum Disorder Market Insights, Epidemiology and Market Forecast-2030
DelveInsight's "Neuromyelitis Optica Spectrum Disorder (NMOSD) - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Neuromyelitis Optica Spectrum Disorder (NMOSD), historical and forecasted epidemiology as well as the Neuromyelitis Optica Spectrum Disorder (NMOSD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Neuromyelitis Optica Spectrum Disorder (NMOSD) market report provides current treatment practices, emerging drugs, Neuromyelitis Optica Spectrum Disorder (NMOSD) market share of the individual therapies, current and forecasted Neuromyelitis Optica Spectrum Disorder (NMOSD) market Size from 2017 to 2030 segmented by seven major markets. The Report also covers current Neuromyelitis Optica Spectrum Disorder (NMOSD) treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
According to National Multiple Sclerosis Society, Neuromyelitis optica (NMO) and NMO Spectrum Disorder (NMOSD), also known as Devic's disease, is an autoimmune disorder in which immune system cells and antibodies primarily attack the optic nerves and the spinal cord, but may also attack the brain. The damage to the optic nerves produces swelling and inflammation that cause pain and loss of vision; the damage to the spinal cord causes weakness or paralysis in the legs or arms, loss of sensation, and problems with bladder and bowel function. There are two forms of NMO/NMOSD: Relapsing and Monophasic.
Request for :- NMOSD free sample page
Epidemiology
The Neuromyelitis Optica Spectrum Disorder (NMOSD) epidemiology division provide insights about historical and current Neuromyelitis Optica Spectrum Disorder (NMOSD) patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Report Key facts :-
1. According to a study “Prevalence and clinical features of neuromyelitis optica spectrum disorders in northern Japan” 2017 conducted by Keiko Tanaka et al, the crude prevalence was 4.1/100,000 (95% confidence interval 2.2–6.9) for NMOSD in northern Japan, with a significantly higher number of female than male patients (female: male 12:2). The positivity for anti-aquaporin-4 antibody was 78.6%, and the mean age at onset was 45.2 years.
2. According to a study “Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta- Analysis” 2015, conducted by RezaVosoughiet al, the prevalence rate of 0.72/100000 (95% CI 0.31–1.42) and minimum combined average annual incidence rate of 0.08/100000 (95% CI 0.03–0.16) indicated that NMO is still an uncommon condition in UK adults.
key companies working on NMOSD that are given below:-
1. Chugai Pharmaceutical
2. Alexion Pharma
Name of drugs covered are given below:-
1. Satralizumab (SA237)
2. Soliris
1. Key Insights
2. Executive Summary of Neuromyelitis Optica Spectrum Disorder (NMOSD)
3. Competitive Intelligence Analysis for Neuromyelitis Optica Spectrum Disorder (NMOSD)
4. Neuromyelitis Optica Spectrum Disorder (NMOSD): Market Overview at a Glance
4.1. Neuromyelitis Optica Spectrum Disorder (NMOSD) Total Market Share (%) Distribution in 2017
4.2. Neuromyelitis Optica Spectrum Disorder (NMOSD) Total Market Share (%) Distribution in 2030
5. Neuromyelitis Optica Spectrum Disorder (NMOSD): Disease Background and Overview
6. Patient Journey
7. Neuromyelitis Optica Spectrum Disorder (NMOSD) Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
8.1. Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment and Management
8.2. Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment
11. Marketed Products
12. Emerging Therapies
13. Neuromyelitis Optica Spectrum Disorder (NMOSD): Seven Major Market Analysis
13.1. Key Findings
13.2. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size in 7MM
13.3. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size by Therapies in the 7MM
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Neuromyelitis Optica Spectrum Disorder (NMOSD)
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
20.1. Bibliography
20.2. Report Methodology
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Why should you buy this report?
- The report will help in developing business strategies by understanding trends shaping and driving the Neuromyelitis Optica Spectrum Disorder (NMOSD) market
- To understand the future market competition in the Neuromyelitis Optica Spectrum Disorder (NMOSD) market and Insightful review of the key market drivers and barriers
- Organize sales and marketing efforts by identifying the best opportunities for Neuromyelitis Optica Spectrum Disorder (NMOSD) in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
- Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
- Organize sales and marketing efforts by identifying the best opportunities for Neuromyelitis Optica Spectrum Disorder (NMOSD) market
- To understand the future market competition in the Neuromyelitis Optica Spectrum Disorder (NMOSD) market
Related Reports:-
1. Neuromyelitis Optica Market Insight, Epidemiology and Market Forecast -2030
2. Neuromyelitis Optica Spectrum Disorder (NMOSD) - Epidemiology Forecast to 2030
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
